
Loading, please wait...

Loading, please wait...

The clinical management of a basilar perforator pseudoaneurysm remains a formidable challenge for neurosurgeons and neurologists alike. These rare vascular lesions often manifest as subarachnoid hemorrhage (SAH) and demand a high index of suspicion. Because initial imaging frequently fails to detect these small lesions, clinicians must prioritize repeat vascular studies to avoid misdiagnosis. A recent case study involving a 74-year-old man illustrates the complexities of navigating this rare pathology in a high-risk patient.
Diagnosis is notoriously difficult because a basilar perforator pseudoaneurysm can be occult on initial computed tomography angiography (CTA) or digital subtraction angiography (DSA). In this specific case, the patient presented with diffuse SAH and intraventricular extension. While initial studies might be negative, repeat DSA eventually revealed a pseudoaneurysm arising from a basilar perforator. Consequently, medical experts emphasize that 3D rotational angiography is essential when posterior-circulation SAH lacks an obvious source. Furthermore, the slow flow within small-caliber perforating arteries often masks the lesion during the early arterial phase of standard imaging.
Deciding between active intervention and conservative management is often difficult. Endovascular embolization carries significant risks, such as perforator occlusion or the dangerous need for antiplatelet therapy during acute SAH. Similarly, open surgery presents extreme challenges due to deep exposure and the lack of proximal or distal control. In this patient, the medical team pursued conservative management because the procedural risks were prohibitive. Interestingly, repeat imaging later showed spontaneous thrombosis of the pseudoaneurysm. However, radiographic resolution does not always translate to clinical recovery. Despite the aneurysm's disappearance, the patient suffered from severe vasospasm and infarction, ultimately leading to death. Therefore, intensive neurocritical care remains the cornerstone of management, regardless of the chosen surgical or endovascular path.
Clinicians often miss basilar perforator pseudoaneurysms on initial imaging due to their small size and slow opacification. Therefore, repeat digital subtraction angiography (DSA) with 3D rotational views is vital to identify the bleeding source if initial studies are negative.
The main risks include the accidental occlusion of the parent perforator artery, which can cause significant brainstem infarction. Additionally, using flow-diverting stents requires dual antiplatelet therapy, which is highly risky in the setting of an acute, unsecured subarachnoid hemorrhage.
Yes, literature indicates a high rate of spontaneous thrombosis in these lesions. Nevertheless, patients still face high mortality risks from secondary complications like vasospasm, hydrocephalus, and delayed cerebral ischemia.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Lhamo T et al. Subarachnoid hemorrhage from a basilar artery perforator pseudoaneurysm: a rare challenging lesion in the posterior circulation. Illustrative case. J Neurosurg Case Lessons. 2026 May 18. doi: undefined. PMID: 42150195.
2. Venegas A et al. Basilar Artery Perforator Aneurysms: A Single-Center Experience with Conservative Management. J Neurosurg Case Lessons. 2026. PMC1104432.
3. Satti SR et al. Management of Intracranial Perforator Aneurysms. Stroke: Vascular and Interventional Neurology. 2025. doi:10.1161/SVIN.124.001256.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This case study explores the management of a rare basilar perforator pseudoaneurysm, highlighting diagnostic hurdles and the risks of therapeutic interventi...
5 months ago

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A novel calcium polyphosphate coacervate enables injectable bone implants with in situ hierarchical porosity via phase separation and gas foaming, significantly enhancing cell proliferation, energy metabolism, and osteogenic differentiation for minimally invasive bone defect repair.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today